Discrepancy between the European clinical guidelines and myocardial revascularization in patients with stable coronary artery disease in Russia

被引:1
|
作者
Kiselev, Anton R. [1 ]
Korotin, Alexey S. [1 ]
Posnenkova, Olga M. [1 ]
Popova, Yulia V. [1 ]
Prokhorov, Mikhail D. [2 ]
Gridnev, Vladimir I. [1 ]
机构
[1] Saratov State Med Univ, Dept New Cardiol Informat Technol, Res Inst Cardiol, 112 Bolshaya Kazachya Str, Saratov 410012, Russia
[2] Russian Acad Sci, Saratov Branch, Lab Nonlinear Dynam Modelling, Inst Radio Engn & Elect, Saratov 410019, Russia
关键词
coronary artery disease; myocardial revascularization; ESC; EACTS guidelines; clinical indications; OPTIMAL MEDICAL THERAPY; ISCHEMIC-HEART-DISEASE; BYPASS GRAFT-SURGERY; INTERVENTION; MANAGEMENT; LIFE; PCI;
D O I
10.1093/intqhc/mzy140
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines, six indications have been proposed for making a decision on myocardial revascularization in patients with stable coronary artery disease (CAD). Our aim was to study a discrepancy between the actual clinical situation and ESC/EACTS indications on performing the revascularization in patients with CAD in Russia. We used retrospective clinical data on patients with stable CAD enrolled in the 20122015 Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure. A total of 1522 patients with CAD (aged 53.0 8.5 years, 76.2% male) were used for analysis. All patients were divided into two groups: 591 patients with performed myocardial revascularization (named as R-CAD) and 931 patients refused from revascularization (named as NR-CAD). Factors associated with revascularization performance were identified by discriminant function analysis. ESC/EACTS indications for revascularization were assessed. A total of 1196 patients with CAD had any ESC/EACTS indication for revascularization, but only 40.2% of them had performed invasive coronary intervention. Myocardial revascularization was appropriate in 81.4% of R-CAD patients and 76.8% of NR-CAD patients. The main factor of revascularization performance was any stenosis > 50% and grades IIIIV of stable angina. With non-performed revascularization, the following factors were associated: limiting angina or angina equivalent, unresponsive to medical therapy, atherosclerotic peripheral arterial disease and increasing the New York Heart Association class of chronic heart failure. Most ESC/EACTS indications had little effect on decision-making on revascularization. There is a discrepancy between the actual clinical situation and ESC/EACTS guidelines on myocardial revascularization in patients with stable CAD in Russia.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [21] MYOCARDIAL REVASCULARIZATION FOR TREATMENT OF CORONARY ARTERY DISEASE
    MONK, I
    DEAL, C
    DONNELLY, GL
    MEDICAL JOURNAL OF AUSTRALIA, 1969, 1 (20) : 1009 - &
  • [22] Evaluation of myocardial perfusion and viability in coronary artery disease in view of the new revascularization guidelines
    Misko, Jolanta
    NUCLEAR MEDICINE REVIEW, 2012, 15 (01) : 46 - 51
  • [23] Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization
    Li, Jiehui
    Yang, Xiubin
    Tian, Yueqin
    Wei, Hongxing
    Hacker, Marcus
    Li, Xiang
    Zhang, Xiaoli
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (03) : 944 - 953
  • [24] Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization
    Jiehui Li
    Xiubin Yang
    Yueqin Tian
    Hongxing Wei
    Marcus Hacker
    Xiang Li
    Xiaoli Zhang
    Journal of Nuclear Cardiology, 2019, 26 : 944 - 953
  • [25] Risk assessment in patients with coronary artery disease undergoing myocardial revascularization
    Ilyukhin, O. V.
    Dronova, E. P.
    Temrisultanova, T. H.
    Lopatin, Y. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 547 - 547
  • [26] Outcomes of myocardial revascularization in patients with obesity and multivessel coronary artery disease
    Madiyeva, Maira I.
    Aripov, Marat A.
    Goncharov, Alexey Y.
    Zholdasbekova, Rakhima Y.
    EGYPTIAN HEART JOURNAL, 2024, 76 (01):
  • [27] Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease
    Rajkumar, Christopher A.
    Wereski, Ryan
    Parsonage, William
    Cullen, Louise
    Khamis, Ramzi
    Foley, Michael
    Harrell, Frank E., Jr.
    Shun-Shin, Matthew J.
    Mills, Nicholas L.
    Al-Lamee, Rasha K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (21) : 2185 - 2187
  • [28] 3D Fusion Between SPECT Myocardial Perfusion Imaging and Invasive Coronary Angiography to Guide Revascularization in Patients With Stable Coronary Artery Disease
    Xu, Zhihui
    Malhotra, Saurabh
    Zhao, Chen
    Li, Chunjian
    Ye, Zekang
    Hua, Rui
    Wang, Cheng
    Zhou, Weihua
    CIRCULATION, 2023, 148
  • [29] When to Consider Coronary Revascularization for Stable Coronary Artery Disease
    Cheng, Andrew M.
    Doll, Jacob A.
    MEDICAL CLINICS OF NORTH AMERICA, 2024, 108 (03) : 517 - 538
  • [30] Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease
    Harutyunyan, Marina
    Johansen, Julia S.
    Mygind, Naja D.
    Reuter, Simon B.
    Kastrup, Jens
    BIOMARKERS IN MEDICINE, 2014, 8 (08) : 977 - 987